Case Series: Genetic mimics of hypertrophic cardiomyopathy in elderly
Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic cardiac disorder, primarily driven by pathogenic nucleotide variants (PNVs) in the genes that encode sarcomeric proteins. Such PNVs cause a disruption of cardiomyocytes. Notably, up to 5% of patients with an HCM phenotype may actually h...
Saved in:
| Main Authors: | Olga S. Chumakova, Olga A. Drobyazko, Elena A. Stepanova, Alexander A. Pushkov, Kirill V. Savostyanov, Dmitry A. Zateyshchikov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1483390/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The clinical use of the MOGE(S) classification in the differential diagnosis between idiopathic hypertrophic cardiomyopathy and its phenocopies
by: A. Poliakova, et al.
Published: (2019-11-01) -
RARE CASES OF HYPERTROPHIC CARDIOMYOPATHY: VARIANTS AND CLINICAL OBSERVATIONS
by: V. Yu. Zimina, et al.
Published: (2015-09-01) -
Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis “Amyloidosis” as a Manifestation of Danon Disease in a Woman
by: O. V. Blagova, et al.
Published: (2020-05-01) -
2020 Clinical practice guidelines for Hypertrophic cardiomyopathy
by: S. A. Gabrusenko, et al.
Published: (2021-06-01) -
AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01)